(Q37784448)

23 August 2017

Advances in pharmacologic modulation of nitric oxide in hypertension (English)

1 reference

23 August 2017

arterial hypertension

0 references

author name string

Yoshiko Mizuno

series ordinal

1

1 reference

PubMed ID

20809234

23 August 2017

Robert F Jacob

series ordinal

2

1 reference

PubMed ID

20809234

23 August 2017

R Preston Mason

series ordinal

3

1 reference

23 August 2017

1 November 2010

1 reference

Current cardiology reports

23 August 2017

1 reference

23 August 2017

12

1 reference

23 August 2017

6

1 reference

23 August 2017

472-480

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-010-0142-5

23 August 2017

0 references

cites work

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Nebivolol decreases systemic oxidative stress in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Molecular physiology of low-voltage-activated t-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-010-0142-5

Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability

21 January 2018

1 reference

12 December 2020

Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats

1 reference

12 December 2020

NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat

1 reference

12 December 2020

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

1 reference

12 December 2020

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

1 reference

12 December 2020

Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action

1 reference

12 December 2020

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers

1 reference

12 December 2020

Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery

1 reference

12 December 2020

Targeting nitric oxide with drug therapy

1 reference

12 December 2020

The (pro)renin receptor: therapeutic consequences

1 reference

12 December 2020

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

1 reference

12 December 2020

Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent

1 reference

12 December 2020

Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats

1 reference

12 December 2020

Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.

1 reference

12 December 2020

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

1 reference

12 December 2020

Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation

1 reference

12 December 2020

Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.

1 reference

12 December 2020

Effects of aldosterone on the vasculature

1 reference

12 December 2020

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

1 reference

12 December 2020

Effects of amlodipine on nitric oxide synthase mRNA expression and coronary microcirculation in prolonged nitric oxide blockade-induced hypertensive rats

1 reference

12 December 2020

Carvedilol reduces plasma 8-hydroxy-2'-deoxyguanosine in mild to moderate hypertension: a pilot study

1 reference

12 December 2020

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

12 December 2020

Synergistic Antihypertensive Effects of Nifedipine on Endothelium : Concurrent Release of NO and Scavenging of Superoxide

1 reference

12 December 2020

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

1 reference

12 December 2020

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

12 December 2020

Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

1 reference

12 December 2020

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

1 reference

12 December 2020

Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity.

1 reference

12 December 2020

Renin inhibition in hypertension

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

1 reference

12 December 2020

Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).

1 reference

12 December 2020

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

1 reference

12 December 2020

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity

1 reference

12 December 2020

Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats

1 reference

12 December 2020

Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans.

1 reference

12 December 2020

Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.

1 reference

12 December 2020

Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells

1 reference

12 December 2020

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

12 December 2020

Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study

1 reference

12 December 2020

Reduced responses of nitrendipine in PGF2 alpha-precontracted porcine isolated arteries after pretreatment with methylene blue

1 reference

12 December 2020

Arterial stiffness, wave reflections, and the risk of coronary artery disease

1 reference

12 December 2020

Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Cellular and molecular mechanisms of endothelial cell dysfunction

1 reference

12 December 2020

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

12 December 2020

Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation

1 reference

12 December 2020

Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells

1 reference

12 December 2020

Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension

1 reference

12 December 2020

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

1 reference

12 December 2020

Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2Receptor

1 reference

12 December 2020

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

1 reference

12 December 2020

Potassium softens vascular endothelium and increases nitric oxide release

1 reference

12 December 2020

Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling

1 reference

12 December 2020

Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview

1 reference

12 December 2020

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

1 reference

12 December 2020

Role of aldosterone and angiotensin II in insulin resistance: an update

1 reference

12 December 2020

Troglitazone, an insulin sensitizer, increases forearm blood flow in humans

1 reference

12 December 2020

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

12 December 2020

10.1007/S11886-010-0142-5

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20809234